| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | heat shock protein binding | 7.83e-06 | 163 | 34 | 5 | GO:0031072 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 5.88e-05 | 7 | 34 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 1.11e-04 | 55 | 34 | 3 | GO:0051879 | |
| GeneOntologyCellularComponent | Atg1/ULK1 kinase complex | 8.64e-05 | 9 | 33 | 2 | GO:1990316 | |
| GeneOntologyCellularComponent | clathrin complex | 8.64e-05 | 9 | 33 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | clathrin coat of trans-Golgi network vesicle | 3.64e-04 | 18 | 33 | 2 | GO:0030130 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 5.47e-04 | 22 | 33 | 2 | GO:0012510 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 1.64e-03 | 38 | 33 | 2 | GO:0030125 | |
| GeneOntologyCellularComponent | phagophore assembly site | 1.73e-03 | 39 | 33 | 2 | GO:0000407 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 1.82e-03 | 40 | 33 | 2 | GO:0030140 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.92e-03 | 157 | 33 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | protein folding chaperone complex | 2.00e-03 | 42 | 33 | 2 | GO:0101031 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.41e-03 | 170 | 33 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | clathrin coat | 3.53e-03 | 56 | 33 | 2 | GO:0030118 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 4.17e-03 | 61 | 33 | 2 | GO:0030660 | |
| GeneOntologyCellularComponent | myelin sheath | 4.78e-03 | 217 | 33 | 3 | GO:0043209 | |
| GeneOntologyCellularComponent | vesicle coat | 5.01e-03 | 67 | 33 | 2 | GO:0030120 | |
| Domain | Clathrin_H-chain_link/propller | 3.22e-06 | 2 | 34 | 2 | IPR016025 | |
| Domain | Clathrin_H-chain_propeller_rpt | 3.22e-06 | 2 | 34 | 2 | IPR022365 | |
| Domain | Clathrin_propel | 3.22e-06 | 2 | 34 | 2 | PF01394 | |
| Domain | Clathrin_heavy_chain | 3.22e-06 | 2 | 34 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_linker_core | 3.22e-06 | 2 | 34 | 2 | IPR015348 | |
| Domain | Clathrin-link | 3.22e-06 | 2 | 34 | 2 | PF09268 | |
| Domain | - | 3.22e-06 | 2 | 34 | 2 | 2.130.10.110 | |
| Domain | Clathrin_H-chain_propeller_N | 3.22e-06 | 2 | 34 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_linker | 9.64e-06 | 3 | 34 | 2 | IPR012331 | |
| Domain | CLH | 9.64e-06 | 3 | 34 | 2 | SM00299 | |
| Domain | Clathrin | 6.72e-05 | 7 | 34 | 2 | PF00637 | |
| Domain | CHCR | 6.72e-05 | 7 | 34 | 2 | PS50236 | |
| Domain | Clathrin_H-chain/VPS_repeat | 8.95e-05 | 8 | 34 | 2 | IPR000547 | |
| Domain | Ser/Thr_kinase_AS | 3.87e-03 | 357 | 34 | 4 | IPR008271 | |
| Domain | S_TKc | 3.95e-03 | 359 | 34 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 4.07e-03 | 362 | 34 | 4 | PS00108 | |
| Domain | Pkinase | 4.87e-03 | 381 | 34 | 4 | PF00069 | |
| Domain | - | 6.23e-03 | 207 | 34 | 3 | 1.25.40.10 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 6.99e-03 | 69 | 34 | 2 | IPR020636 | |
| Pathway | KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION | 9.10e-05 | 8 | 26 | 2 | M47746 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8733129 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29097553 | ||
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 9.84e-07 | 2 | 35 | 2 | 20065094 | |
| Pubmed | The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically. | 9.84e-07 | 2 | 35 | 2 | 12437126 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 28073914 | ||
| Pubmed | 1.05e-06 | 20 | 35 | 3 | 22504172 | ||
| Pubmed | Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. | 2.95e-06 | 3 | 35 | 2 | 19509056 | |
| Pubmed | Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. | 2.95e-06 | 3 | 35 | 2 | 22891263 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19287211 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 1589293 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15133132 | ||
| Pubmed | Structure of the Human Atg13-Atg101 HORMA Heterodimer: an Interaction Hub within the ULK1 Complex. | 2.95e-06 | 3 | 35 | 2 | 26299944 | |
| Pubmed | 3.35e-06 | 29 | 35 | 3 | 21360678 | ||
| Pubmed | 4.53e-06 | 437 | 35 | 6 | 20562859 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 24880080 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 22729780 | ||
| Pubmed | HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. | 5.90e-06 | 4 | 35 | 2 | 11517213 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 6.11e-06 | 1367 | 35 | 9 | 32687490 | |
| Pubmed | 6.31e-06 | 463 | 35 | 6 | 27503909 | ||
| Pubmed | 9.12e-06 | 494 | 35 | 6 | 26831064 | ||
| Pubmed | Autophagic Flux Is Regulated by Interaction Between the C-terminal Domain of PATCHED1 and ATG101. | 9.82e-06 | 5 | 35 | 2 | 29453315 | |
| Pubmed | Atg101, a novel mammalian autophagy protein interacting with Atg13. | 9.82e-06 | 5 | 35 | 2 | 19597335 | |
| Pubmed | Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. | 9.82e-06 | 5 | 35 | 2 | 21855797 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 10436022 | ||
| Pubmed | 1.30e-05 | 803 | 35 | 7 | 36517590 | ||
| Pubmed | ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. | 1.47e-05 | 6 | 35 | 2 | 19225151 | |
| Pubmed | Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. | 1.47e-05 | 6 | 35 | 2 | 24462205 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 18936157 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 1.83e-05 | 156 | 35 | 4 | 30409884 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 1.84e-05 | 327 | 35 | 5 | 15592455 | |
| Pubmed | 1.88e-05 | 51 | 35 | 3 | 36108743 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 20159553 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 15647277 | ||
| Pubmed | Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. | 2.06e-05 | 7 | 35 | 2 | 21460634 | |
| Pubmed | A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. | 2.06e-05 | 7 | 35 | 2 | 27617292 | |
| Pubmed | A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. | 2.06e-05 | 7 | 35 | 2 | 19478182 | |
| Pubmed | AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. | 2.06e-05 | 7 | 35 | 2 | 21258367 | |
| Pubmed | EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability. | 2.36e-05 | 55 | 35 | 3 | 32269044 | |
| Pubmed | Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. | 2.74e-05 | 8 | 35 | 2 | 22315411 | |
| Pubmed | Distinct roles of molecular chaperones HSP90α and HSP90β in the biogenesis of KCNQ4 channels. | 2.74e-05 | 8 | 35 | 2 | 23431407 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 24290141 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 17569659 | ||
| Pubmed | The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. | 2.74e-05 | 8 | 35 | 2 | 30669939 | |
| Pubmed | HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor. | 2.74e-05 | 8 | 35 | 2 | 11809754 | |
| Pubmed | 2.77e-05 | 58 | 35 | 3 | 30009671 | ||
| Pubmed | 3.23e-05 | 61 | 35 | 3 | 19875381 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 29127155 | ||
| Pubmed | FIP200 regulates targeting of Atg16L1 to the isolation membrane. | 3.53e-05 | 9 | 35 | 2 | 23392225 | |
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 26804907 | ||
| Pubmed | 3.91e-05 | 65 | 35 | 3 | 34645483 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 4.38e-05 | 195 | 35 | 4 | 17110338 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 25898166 | ||
| Pubmed | Identification and characterization of Harc, a novel Hsp90-associating relative of Cdc37. | 4.40e-05 | 10 | 35 | 2 | 11413142 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 21956701 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.56e-05 | 197 | 35 | 4 | 29872149 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 29604273 | ||
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 5.84e-05 | 210 | 35 | 4 | 26217791 | |
| Pubmed | Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. | 6.74e-05 | 78 | 35 | 3 | 16236267 | |
| Pubmed | ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. | 7.62e-05 | 13 | 35 | 2 | 21795849 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 7.89e-05 | 1455 | 35 | 8 | 22863883 | |
| Pubmed | HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. | 8.89e-05 | 14 | 35 | 2 | 28739485 | |
| Pubmed | 9.18e-05 | 1487 | 35 | 8 | 33957083 | ||
| Pubmed | Huntingtin functions as a scaffold for selective macroautophagy. | 1.02e-04 | 15 | 35 | 2 | 25686248 | |
| Pubmed | 1.03e-04 | 90 | 35 | 3 | 31280863 | ||
| Pubmed | 1.21e-04 | 786 | 35 | 6 | 29128334 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.26e-04 | 1149 | 35 | 7 | 35446349 | |
| Pubmed | 1.29e-04 | 97 | 35 | 3 | 22360420 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 1.31e-04 | 495 | 35 | 5 | 28581483 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.40e-04 | 807 | 35 | 6 | 30575818 | |
| Pubmed | High-throughput screening of functional deubiquitinating enzymes in autophagy. | 1.49e-04 | 18 | 35 | 2 | 32453962 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.82e-04 | 847 | 35 | 6 | 35235311 | |
| Pubmed | 1.86e-04 | 534 | 35 | 5 | 35032548 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.97e-04 | 288 | 35 | 4 | 31501420 | |
| Pubmed | Motor neurons control blood vessel patterning in the developing spinal cord. | 2.04e-04 | 21 | 35 | 2 | 28262664 | |
| Pubmed | The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. | 2.04e-04 | 21 | 35 | 2 | 27353360 | |
| Pubmed | 2.04e-04 | 21 | 35 | 2 | 14532270 | ||
| Pubmed | Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. | 2.19e-04 | 116 | 35 | 3 | 37117180 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 2.28e-04 | 558 | 35 | 5 | 35063084 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 2.57e-04 | 573 | 35 | 5 | 28330616 | |
| Pubmed | 2.65e-04 | 1297 | 35 | 7 | 33545068 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.90e-04 | 588 | 35 | 5 | 38580884 | |
| Pubmed | 3.15e-04 | 26 | 35 | 2 | 24067654 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.35e-04 | 607 | 35 | 5 | 39147351 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.38e-04 | 332 | 35 | 4 | 32786267 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.43e-04 | 1353 | 35 | 7 | 29467282 | |
| Pubmed | 4.09e-04 | 634 | 35 | 5 | 34591612 | ||
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 4.13e-04 | 350 | 35 | 4 | 26549023 | |
| Pubmed | 4.20e-04 | 30 | 35 | 2 | 25864199 | ||
| Pubmed | Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP. | 4.20e-04 | 30 | 35 | 2 | 22963397 | |
| Pubmed | 4.20e-04 | 30 | 35 | 2 | 16027165 | ||
| Pubmed | 4.30e-04 | 146 | 35 | 3 | 29509794 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 4.49e-04 | 647 | 35 | 5 | 26618866 | |
| Pubmed | 4.49e-04 | 31 | 35 | 2 | 19666558 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.69e-04 | 1425 | 35 | 7 | 30948266 | |
| Pubmed | 4.93e-04 | 153 | 35 | 3 | 27462432 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.02e-04 | 1024 | 35 | 6 | 24711643 | |
| Pubmed | Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. | 5.09e-04 | 33 | 35 | 2 | 16000382 | |
| Pubmed | Atypical E2F repressors and activators coordinate placental development. | 5.09e-04 | 33 | 35 | 2 | 22516201 | |
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 5.51e-04 | 159 | 35 | 3 | 36762613 | |
| Pubmed | 5.70e-04 | 1049 | 35 | 6 | 27880917 | ||
| Interaction | STAMBP interactions | 7.03e-07 | 104 | 33 | 5 | int:STAMBP | |
| Interaction | COPG1 interactions | 1.73e-06 | 229 | 33 | 6 | int:COPG1 | |
| Interaction | MAP1LC3A interactions | 2.32e-06 | 241 | 33 | 6 | int:MAP1LC3A | |
| Interaction | STAMBPL1 interactions | 6.67e-06 | 75 | 33 | 4 | int:STAMBPL1 | |
| Interaction | UCHL3 interactions | 1.19e-05 | 185 | 33 | 5 | int:UCHL3 | |
| Interaction | OFD1 interactions | 1.87e-05 | 347 | 33 | 6 | int:OFD1 | |
| Interaction | HAX1 interactions | 4.38e-05 | 404 | 33 | 6 | int:HAX1 | |
| Interaction | WRAP73 interactions | 4.71e-05 | 123 | 33 | 4 | int:WRAP73 | |
| Interaction | WASHC3 interactions | 6.58e-05 | 134 | 33 | 4 | int:WASHC3 | |
| Interaction | CDC37 interactions | 6.88e-05 | 645 | 33 | 7 | int:CDC37 | |
| Interaction | SNX5 interactions | 7.18e-05 | 137 | 33 | 4 | int:SNX5 | |
| Interaction | RIPK4 interactions | 7.58e-05 | 446 | 33 | 6 | int:RIPK4 | |
| Interaction | WDFY4 interactions | 8.02e-05 | 141 | 33 | 4 | int:WDFY4 | |
| Interaction | GABARAP interactions | 8.94e-05 | 145 | 33 | 4 | int:GABARAP | |
| Interaction | CDK10 interactions | 9.37e-05 | 54 | 33 | 3 | int:CDK10 | |
| Interaction | USP19 interactions | 1.13e-04 | 154 | 33 | 4 | int:USP19 | |
| Interaction | BRCA1 interactions | 1.30e-04 | 1249 | 33 | 9 | int:BRCA1 | |
| Interaction | YWHAE interactions | 1.36e-04 | 1256 | 33 | 9 | int:YWHAE | |
| Interaction | HSP90AA1 interactions | 1.42e-04 | 1263 | 33 | 9 | int:HSP90AA1 | |
| Interaction | ATG14 interactions | 1.95e-04 | 69 | 33 | 3 | int:ATG14 | |
| Interaction | CFAP52 interactions | 2.01e-04 | 13 | 33 | 2 | int:CFAP52 | |
| Interaction | SNAP91 interactions | 2.03e-04 | 70 | 33 | 3 | int:SNAP91 | |
| Interaction | BAG5 interactions | 2.17e-04 | 341 | 33 | 5 | int:BAG5 | |
| Interaction | MAP1LC3C interactions | 2.21e-04 | 72 | 33 | 3 | int:MAP1LC3C | |
| Interaction | CLTB interactions | 2.28e-04 | 185 | 33 | 4 | int:CLTB | |
| Interaction | USP15 interactions | 2.29e-04 | 546 | 33 | 6 | int:USP15 | |
| Interaction | AKR1B15 interactions | 2.34e-04 | 14 | 33 | 2 | int:AKR1B15 | |
| Interaction | FBXO43 interactions | 2.40e-04 | 74 | 33 | 3 | int:FBXO43 | |
| Interaction | STIL interactions | 2.53e-04 | 190 | 33 | 4 | int:STIL | |
| Interaction | FAM120C interactions | 2.58e-04 | 191 | 33 | 4 | int:FAM120C | |
| Interaction | KCNQ4 interactions | 2.69e-04 | 15 | 33 | 2 | int:KCNQ4 | |
| Interaction | SCYL2 interactions | 2.79e-04 | 195 | 33 | 4 | int:SCYL2 | |
| Interaction | DDX39B interactions | 2.88e-04 | 570 | 33 | 6 | int:DDX39B | |
| Interaction | KCTD10 interactions | 2.96e-04 | 198 | 33 | 4 | int:KCTD10 | |
| Interaction | PRKAG3 interactions | 3.02e-04 | 80 | 33 | 3 | int:PRKAG3 | |
| Interaction | NELFE interactions | 3.13e-04 | 201 | 33 | 4 | int:NELFE | |
| Interaction | LDHA interactions | 3.36e-04 | 375 | 33 | 5 | int:LDHA | |
| Interaction | G3BP1 interactions | 3.40e-04 | 835 | 33 | 7 | int:G3BP1 | |
| Interaction | SUMO2 interactions | 3.50e-04 | 591 | 33 | 6 | int:SUMO2 | |
| Interaction | CLINT1 interactions | 3.50e-04 | 207 | 33 | 4 | int:CLINT1 | |
| Interaction | CCT6B interactions | 3.50e-04 | 207 | 33 | 4 | int:CCT6B | |
| Interaction | FBXO7 interactions | 3.72e-04 | 598 | 33 | 6 | int:FBXO7 | |
| Interaction | SUMO4 interactions | 3.73e-04 | 86 | 33 | 3 | int:SUMO4 | |
| Interaction | USO1 interactions | 4.04e-04 | 215 | 33 | 4 | int:USO1 | |
| Interaction | WIPI2 interactions | 4.26e-04 | 90 | 33 | 3 | int:WIPI2 | |
| Interaction | ATG16L1 interactions | 4.51e-04 | 1161 | 33 | 8 | int:ATG16L1 | |
| Interaction | SLC35B2 interactions | 4.55e-04 | 92 | 33 | 3 | int:SLC35B2 | |
| Interaction | TBK1 interactions | 4.61e-04 | 402 | 33 | 5 | int:TBK1 | |
| Interaction | CFTR interactions | 4.65e-04 | 1480 | 33 | 9 | int:CFTR | |
| Interaction | ATG101 interactions | 4.84e-04 | 94 | 33 | 3 | int:ATG101 | |
| Interaction | FNIP2 interactions | 4.85e-04 | 20 | 33 | 2 | int:FNIP2 | |
| Interaction | BTBD3 interactions | 4.85e-04 | 20 | 33 | 2 | int:BTBD3 | |
| Interaction | PLCE1 interactions | 4.85e-04 | 20 | 33 | 2 | int:PLCE1 | |
| Interaction | UNC45A interactions | 5.05e-04 | 228 | 33 | 4 | int:UNC45A | |
| Interaction | OPTN interactions | 5.75e-04 | 422 | 33 | 5 | int:OPTN | |
| Interaction | FLCN interactions | 5.80e-04 | 100 | 33 | 3 | int:FLCN | |
| Interaction | U2AF2 interactions | 5.84e-04 | 651 | 33 | 6 | int:U2AF2 | |
| Interaction | ATP6V1B2 interactions | 5.93e-04 | 238 | 33 | 4 | int:ATP6V1B2 | |
| Interaction | PRKACG interactions | 5.98e-04 | 101 | 33 | 3 | int:PRKACG | |
| Interaction | DENND1A interactions | 5.98e-04 | 101 | 33 | 3 | int:DENND1A | |
| Interaction | U2AF1 interactions | 6.02e-04 | 239 | 33 | 4 | int:U2AF1 | |
| Interaction | DISC1 interactions | 6.20e-04 | 429 | 33 | 5 | int:DISC1 | |
| Interaction | CDK5 interactions | 6.31e-04 | 242 | 33 | 4 | int:CDK5 | |
| Interaction | HSPA4 interactions | 6.63e-04 | 667 | 33 | 6 | int:HSPA4 | |
| Interaction | TFCP2 interactions | 6.67e-04 | 436 | 33 | 5 | int:TFCP2 | |
| Interaction | FAM221B interactions | 7.02e-04 | 24 | 33 | 2 | int:FAM221B | |
| Interaction | ASB5 interactions | 7.02e-04 | 24 | 33 | 2 | int:ASB5 | |
| Interaction | PINK1 interactions | 7.28e-04 | 679 | 33 | 6 | int:PINK1 | |
| Interaction | GRK7 interactions | 7.62e-04 | 25 | 33 | 2 | int:GRK7 | |
| Interaction | WRN interactions | 7.66e-04 | 110 | 33 | 3 | int:WRN | |
| Interaction | PPT1 interactions | 7.79e-04 | 256 | 33 | 4 | int:PPT1 | |
| Interaction | PPP6R3 interactions | 8.02e-04 | 258 | 33 | 4 | int:PPP6R3 | |
| Interaction | FBXO42 interactions | 8.13e-04 | 259 | 33 | 4 | int:FBXO42 | |
| Interaction | CT45A1 interactions | 8.25e-04 | 26 | 33 | 2 | int:CT45A1 | |
| Interaction | VARS1 interactions | 8.25e-04 | 260 | 33 | 4 | int:VARS1 | |
| Interaction | DNAJB5 interactions | 8.50e-04 | 114 | 33 | 3 | int:DNAJB5 | |
| Interaction | RBMX interactions | 8.57e-04 | 461 | 33 | 5 | int:RBMX | |
| Interaction | PAICS interactions | 8.61e-04 | 263 | 33 | 4 | int:PAICS | |
| Interaction | FUCA1 interactions | 8.90e-04 | 27 | 33 | 2 | int:FUCA1 | |
| Interaction | AGRN interactions | 9.11e-04 | 267 | 33 | 4 | int:AGRN | |
| Interaction | VPS35 interactions | 9.50e-04 | 270 | 33 | 4 | int:VPS35 | |
| Interaction | STRAP interactions | 9.50e-04 | 270 | 33 | 4 | int:STRAP | |
| Interaction | EPHA2 interactions | 9.81e-04 | 719 | 33 | 6 | int:EPHA2 | |
| Interaction | LAMTOR1 interactions | 1.00e-03 | 722 | 33 | 6 | int:LAMTOR1 | |
| Interaction | ACTR1A interactions | 1.00e-03 | 274 | 33 | 4 | int:ACTR1A | |
| Interaction | PGAM5 interactions | 1.00e-03 | 274 | 33 | 4 | int:PGAM5 | |
| Interaction | GEMIN4 interactions | 1.00e-03 | 274 | 33 | 4 | int:GEMIN4 | |
| Interaction | PRKCG interactions | 1.01e-03 | 121 | 33 | 3 | int:PRKCG | |
| Interaction | LONP1 interactions | 1.02e-03 | 479 | 33 | 5 | int:LONP1 | |
| Interaction | BAP1 interactions | 1.02e-03 | 1314 | 33 | 8 | int:BAP1 | |
| Interaction | PACRG interactions | 1.03e-03 | 29 | 33 | 2 | int:PACRG | |
| Interaction | STIP1 interactions | 1.03e-03 | 1006 | 33 | 7 | int:STIP1 | |
| Interaction | EIF3H interactions | 1.12e-03 | 282 | 33 | 4 | int:EIF3H | |
| Interaction | PPP1CC interactions | 1.12e-03 | 738 | 33 | 6 | int:PPP1CC | |
| Interaction | RIOK2 interactions | 1.14e-03 | 126 | 33 | 3 | int:RIOK2 | |
| Interaction | ANKK1 interactions | 1.17e-03 | 31 | 33 | 2 | int:ANKK1 | |
| Interaction | MCM6 interactions | 1.19e-03 | 287 | 33 | 4 | int:MCM6 | |
| Interaction | PKM interactions | 1.20e-03 | 497 | 33 | 5 | int:PKM | |
| Interaction | CCDC14 interactions | 1.21e-03 | 129 | 33 | 3 | int:CCDC14 | |
| Interaction | AHSA1 interactions | 1.30e-03 | 294 | 33 | 4 | int:AHSA1 | |
| GeneFamily | Autophagy related | 6.64e-04 | 33 | 21 | 2 | 1022 | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 4.81e-07 | 200 | 35 | 5 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 181 | 35 | 4 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 181 | 35 | 4 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 183 | 35 | 4 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | Transverse|World / Region, Cell class and subclass | 1.78e-05 | 200 | 35 | 4 | 9dee983d7e43af8b3fbed795d8432af67b33c3b3 | |
| ToppCell | Transverse|World / shred on region, Cell_type, and subtype | 1.78e-05 | 200 | 35 | 4 | 1b4925a17be02f99b69c45f66577986a2dc107fd | |
| Computational | DRG (dorsal root ganglia) genes. | 1.20e-04 | 384 | 23 | 6 | MODULE_2 | |
| Drug | 2evm | 1.90e-06 | 60 | 34 | 4 | CID000736259 | |
| Drug | Badg | 2.16e-06 | 2 | 34 | 2 | CID000125951 | |
| Drug | Acth(11-24) | 4.60e-06 | 22 | 34 | 3 | CID003037130 | |
| Drug | AC1OAR8J | 1.30e-05 | 4 | 34 | 2 | CID006834124 | |
| Drug | N5-sulfono Flavin-adenine Dinucleotide | 1.33e-05 | 31 | 34 | 3 | CID011840982 | |
| Drug | AC1L1IPS | 3.23e-05 | 6 | 34 | 2 | CID000004682 | |
| Drug | norfloxacin | 4.14e-05 | 45 | 34 | 3 | CID000004539 | |
| Drug | Dynasore hydrate | 4.52e-05 | 7 | 34 | 2 | CID005396227 | |
| Drug | C12-NBD-PC | 4.52e-05 | 7 | 34 | 2 | CID006439314 | |
| Drug | gallium nitride | 4.52e-05 | 7 | 34 | 2 | CID000117559 | |
| Drug | NSC330499 | 4.52e-05 | 7 | 34 | 2 | CID000433447 | |
| Drug | Na 7 | 6.03e-05 | 8 | 34 | 2 | CID000446006 | |
| Drug | Antagonist G | 7.74e-05 | 9 | 34 | 2 | CID000163960 | |
| Drug | 4P-PDOT | 7.74e-05 | 9 | 34 | 2 | CID003976006 | |
| Drug | Capecitabine | 8.42e-05 | 57 | 34 | 3 | ctd:D000069287 | |
| Drug | cc-637 | 9.67e-05 | 10 | 34 | 2 | CID000002350 | |
| Drug | tetramethylrhodamine-5-maleimide | 9.67e-05 | 10 | 34 | 2 | CID005289288 | |
| Drug | acetylaminophenylarsine oxide | 9.67e-05 | 10 | 34 | 2 | CID006337999 | |
| Drug | 3,6-anhydro-D-galactose 2-sulfate | 1.25e-04 | 65 | 34 | 3 | CID000446806 | |
| Drug | hematoxilina | 1.55e-04 | 183 | 34 | 4 | CID000010603 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HG-U133A | 1.65e-04 | 186 | 34 | 4 | 432_UP | |
| Drug | maslinic acid | 1.67e-04 | 13 | 34 | 2 | ctd:C412811 | |
| Drug | 5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA | 1.69e-04 | 187 | 34 | 4 | 868_UP | |
| Drug | pyrvinium pamoate; Down 200; 1.25uM; MCF7; HT_HG-U133A_EA | 1.79e-04 | 190 | 34 | 4 | 870_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 1661_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 2949_DN | |
| Drug | thiocarbohydrazide | 1.95e-04 | 14 | 34 | 2 | CID002724189 | |
| Drug | diaminoguanidine | 1.95e-04 | 14 | 34 | 2 | CID000151203 | |
| Drug | N-Q-I | 1.95e-04 | 14 | 34 | 2 | CID015942689 | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 3525_DN | |
| Drug | Dioxybenzone [131-53-3]; Down 200; 16.4uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 3101_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 5111_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7374_UP | |
| Drug | AC1L1BEH | 2.14e-04 | 78 | 34 | 3 | CID000001404 | |
| Drug | radicicol | 2.31e-04 | 203 | 34 | 4 | CID000005033 | |
| Drug | Trileucine | 2.56e-04 | 16 | 34 | 2 | CID000082546 | |
| Drug | VAL-TYR | 2.56e-04 | 16 | 34 | 2 | CID004065033 | |
| Drug | PE-W | 2.56e-04 | 16 | 34 | 2 | CID016040251 | |
| Disease | primary biliary cholangitis (is_marker_for) | 3.58e-04 | 25 | 33 | 2 | DOID:12236 (is_marker_for) | |
| Disease | refractive error | 4.65e-04 | 326 | 33 | 4 | MONDO_0004892 | |
| Disease | serum gamma-glutamyl transferase measurement | 4.70e-04 | 914 | 33 | 6 | EFO_0004532 | |
| Disease | Non-Small Cell Lung Carcinoma | 7.04e-04 | 156 | 33 | 3 | C0007131 | |
| Disease | hypertension (is_marker_for) | 1.61e-03 | 53 | 33 | 2 | DOID:10763 (is_marker_for) | |
| Disease | vascular endothelial growth factor measurement | 1.80e-03 | 56 | 33 | 2 | EFO_0004762 | |
| Disease | Atherogenesis | 1.99e-03 | 59 | 33 | 2 | C1563937 | |
| Disease | Atherosclerosis | 1.99e-03 | 59 | 33 | 2 | C0004153 | |
| Disease | body fat percentage | 2.07e-03 | 488 | 33 | 4 | EFO_0007800 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.27e-03 | 63 | 33 | 2 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.27e-03 | 63 | 33 | 2 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 2.34e-03 | 64 | 33 | 2 | EFO_0022253 | |
| Disease | Neoplasms, Experimental | 2.49e-03 | 66 | 33 | 2 | C0027659 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.72e-03 | 69 | 33 | 2 | EFO_0022341 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 2.72e-03 | 69 | 33 | 2 | EFO_0007788, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILKKEDEIRAADCCR | 796 | O15013 | |
| VKACLRRKVCEQEEK | 636 | Q99728 | |
| DRCKSCNGRKIVREK | 191 | P31689 | |
| KRIERAVEEKACNCL | 326 | P09104 | |
| CESLEQEARKKQRRC | 351 | O95153 | |
| RRKCQECRLRKCKEM | 186 | Q96RI1 | |
| KIRQKVDDCERCREF | 961 | Q9Y3P9 | |
| ECGKKLVEVARRCRD | 201 | Q6UB28 | |
| IKCQVVKEIRCLGRK | 126 | P0DMU9 | |
| ICENTCKEKGRKERE | 111 | P14314 | |
| KTSGEIIRCEKCKRE | 131 | Q9C098 | |
| IIRCEKCKRERELQQ | 136 | Q9C098 | |
| RNIREVKCRVVTCKT | 771 | Q7L590 | |
| KECRLRTEECQLQLK | 191 | Q6ZMI0 | |
| RVKKCLICKEQVQSR | 846 | Q86YT6 | |
| CRKRKISSKDICQDR | 96 | A6NGY1 | |
| ERQICREKVGEKLCE | 136 | Q9BSB4 | |
| KNVRVKERSRACLEC | 426 | Q8N9C0 | |
| LECEQIRLKCIRKEG | 6 | Q15131 | |
| EKEELDRGCRECKRK | 46 | Q16543 | |
| ECKRKVAECQRKLKE | 56 | Q16543 | |
| ERIVLVDNKCKCARI | 26 | P01591 | |
| CKREERICQKVIIKS | 2261 | Q3ZCN5 | |
| EVIERKRCVCKEIKA | 781 | Q6ZVC0 | |
| NKCRELCEKAIEVGR | 276 | P31948 | |
| VRRFCKNDREVKKSV | 326 | Q9P212 | |
| CRNVKERITRECKEK | 541 | O00116 | |
| CKTGQIKEVERICRE | 736 | Q00610 | |
| CKTGQIKEVERICRE | 736 | P53675 | |
| KCRLASRTDICEEKK | 211 | Q9BXU1 | |
| VCDRCRQKTRSTKKL | 436 | Q9UK80 | |
| LCTNCRKVLRKDKRI | 16 | P58005 | |
| ERDKTKLRALKCRQC | 1256 | Q96JM2 | |
| EILCEVCRKTFKRKD | 216 | Q92664 | |
| RRCDIIIISGRKEKC | 946 | Q00341 | |
| NKCECRPKKDRARQE | 126 | P15692 | |
| DIENVTKCKLCIERR | 1026 | O75385 |